MediPharm Labs Corp.
LABS.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.94M | 12.03M | 12.69M | 13.82M | 10.52M |
| Total Receivables | 4.95M | 4.54M | 4.77M | 4.44M | 10.30M |
| Inventory | 6.70M | 6.93M | 7.15M | 7.49M | 7.57M |
| Prepaid Expenses | 495.90K | 630.50K | 172.80K | 480.80K | 666.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.50M | 3.57M | 900.20K | 1.51M | 1.74M |
| Total Current Assets | 25.59M | 27.71M | 25.68M | 27.74M | 30.81M |
|
|
|||||
| Total Current Assets | 25.59M | 27.71M | 25.68M | 27.74M | 30.81M |
| Net Property, Plant & Equipment | 14.53M | 14.66M | 18.09M | 19.14M | 18.67M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 664.70K | 689.00K | 728.90K | 781.40K | 796.20K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 553.70K | 661.20K | 727.40K | 757.20K | -- |
| Total Assets | 41.34M | 43.72M | 45.23M | 48.41M | 50.27M |
|
|
|||||
| Total Accounts Payable | 2.60M | 1.94M | 2.67M | 1.61M | 1.79M |
| Total Accrued Expenses | 3.80M | 3.98M | 2.88M | 3.71M | 3.95M |
| Short-term Debt | 422.70K | 1.98M | 1.46M | 1.59M | 1.82M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 35.50K | 38.00K | 59.10K | 91.60K | 131.60K |
| Total Finance Division Other Current Liabilities | 1.11M | 967.40K | 1.30M | 1.21M | 1.71M |
| Total Other Current Liabilities | 1.11M | 967.40K | 1.30M | 1.21M | 1.71M |
| Total Current Liabilities | 7.96M | 8.90M | 8.37M | 8.23M | 9.41M |
|
|
|||||
| Total Current Liabilities | 7.96M | 8.90M | 8.37M | 8.23M | 9.41M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 422.70K | 1.98M | 1.46M | 1.59M | 1.82M |
| Capital Leases | 25.90K | 34.30K | 42.80K | 52.20K | 58.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.99M | 8.94M | 8.41M | 8.28M | 9.47M |
|
|
|||||
| Common Stock & APIC | 148.75M | 146.82M | 148.01M | 151.63M | 147.85M |
| Retained Earnings | -137.46M | -133.65M | -133.18M | -133.82M | -128.45M |
| Treasury Stock & Other | 22.06M | 21.62M | 21.99M | 22.33M | 21.41M |
| Total Common Equity | 33.35M | 34.79M | 36.82M | 40.14M | 40.81M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 33.35M | 34.79M | 36.82M | 40.14M | 40.81M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 33.35M | 34.79M | 36.82M | 40.14M | 40.81M |
|
|
|||||
